A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zhejiang Cancer Hospital
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven non-small cell lung cancer (non-squamous cell carcinoma)
Presence of measurable disease by RECIST
Inoperable stage IIIA or IIIB
ECOG performance status 0-1
No prior chemotherapy, radiation therapy to chest, immunotherapy, or biologic therapy
Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policy of the hospital.
You may not be if
Carcinoid tumor, small cell carcinoma of lung
Patients with any distant metastasis
History of another malignancy within the last five years except cured basal cell carcinoma of skin and cured carcinoma in-situ of uterine cervix Any other morbidity or situation with contraindication for chemotherapy (e.g. active infection, myocardial infarction preceding 6 months, symptomatic heart disease including unstable angina, congestive heart failure or uncontrolled arrhythmias, immunosuppressive treatment)
Pregnant or lactating women, women who has not taken test of pregnancy (within 14 days before the first administration) and pregnant women
Women and men of childbearing potential who have no willing of employing adequate contraception
Clareo Health | A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
